Jazz Pharmaceuticals (JAZZ) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist

138.950
-1.270-0.91%

Close Mar 4 16:00 ET

138.950
0.0000.00%

Post 20:01 ET

8.44BMarket Cap16.06P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: Chairman & CEO of $JAZZ Sells 6,500 Shares
Quiver QuantitativeMar 3 19:16 ET
Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?
Zacks Mar 3 11:35 ET
Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
Zacks Mar 3 09:00 ET
Jazz Pharmaceuticals (JAZZ) Is a Top-Ranked Growth Stock: Should You Buy?
Zacks Feb 28 08:50 ET
Jazz Pharmaceuticals Plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Yahoo FinanceFeb 28 05:39 ET
Truist Financial Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating
Moomoo NewsFeb 28 00:32 ET · Ratings

Comments

Clintzilla

Feb 5 13:08

$Jazz Pharmaceuticals (JAZZ.US)$ just so you all know that this and $Sarepta Therapeutics (SRPT.US)$ are in the same area as $Cumberland Pharmaceuticals (CPIX.US)$ if you wanna know where CPIX price will be in the future

Meltyy

Nov 26, 2024 01:17

🚨 1 PDUFA this week!

See FDA PDUFA update 👇
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...

Stock_Drift

Nov 20, 2024 18:32

$Jazz Pharmaceuticals (JAZZ.US)$

10xStockPicks

Oct 24, 2024 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...